Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Dec 14;13(12):2339.
doi: 10.3390/life13122339.

Fifteen Years after the Definition of Trypanosoma cruzi DTUs: What Have We Learned?

Affiliations
Review

Fifteen Years after the Definition of Trypanosoma cruzi DTUs: What Have We Learned?

Bianca Zingales et al. Life (Basel). .

Abstract

Trypanosoma cruzi, the protozoan causative of Chagas disease (ChD), exhibits striking genetic and phenotypic intraspecific diversity, along with ecoepidemiological complexity. Human-pathogen interactions lead to distinct clinical presentations of ChD. In 2009, an international consensus classified T. cruzi strains into six discrete typing units (DTUs), TcI to TcVI, later including TcBat, and proposed reproducible genotyping schemes for DTU identification. This article aims to review the impact of classifying T. cruzi strains into DTUs on our understanding of biological, ecoepidemiological, and pathogenic aspects of T. cruzi. We will explore the likely origin of DTUs and the intrinsic characteristics of each group of strains concerning genome organization, genomics, and susceptibility to drugs used in ChD treatment. We will also provide an overview of the association of DTUs with mammalian reservoirs, and summarize the geographic distribution, and the clinical implications, of prevalent specific DTUs in ChD patients. Throughout this review, we will emphasize the crucial roles of both parasite and human genetics in defining ChD pathogenesis and chemotherapy outcome.

Keywords: Chagas disease manifestations; Trypanosoma cruzi; discrete typing units; ecoepidemiology; genomics.

PubMed Disclaimer

Conflict of interest statement

We declare no conflict of interest.

Figures

Figure 1
Figure 1
Molecular karyotype of T. cruzi strains representative of four DTUs: TcVI (CL Brener), TcII (Esmeraldo cl3 and Y), TcV (NRcl3, SO3 cl5, and Sc43 cl1), and TcI (Silvio X10 cl1, Dm28c and YuYu). (A) Chromosomal DNA was separated by PFGE and stained with ethidium bromide. After transfer to Zeta-Probe membranes, the blot was hybridized with 32P-labeled probes corresponding to (B) DNA repetitive sequences E12 and 195-bp satellite DNA; and (C) single copy genes B13, B12, and HSP70. See experimental details in [51]. M = Molecular size markers. Reprinted/adapted with permission from Ref. [51]. 2004, Elsevier.
Figure 2
Figure 2
Distribution of T. cruzi DTUs in the sylvatic and domestic cycles of transmission. The figure illustrates the consensus of the preferential, but not exclusive, association of DTUs to certain species/orders of wild mammals. In the domestic cycle, the DTUs prevalent in humans are indicated.

References

    1. World Health Organization Chagas Disease (Also Known as American Trypanosomiasis) 2023. [(accessed on 6 August 2023)]. Available online: https://www.who.int/news-room/fact-sheets/detail/chagas-disease-(america...
    1. De Fuentes-Vicente J.A., Santos-Hernández N.G., Ruiz-Castillejos C., Espinoza-Medinilla E.E., Flores-Villegas A.L., de Alba-Alvarado M., Cabrera-Bravo M., Moreno-Rodríguez A., Vidal-López D.G. What Do You Need to Know before Studying Chagas Disease? A Beginner’s Guide. Trop. Med. Infect. Dis. 2023;8:360. doi: 10.3390/tropicalmed8070360. - DOI - PMC - PubMed
    1. Urbina J.A. Specific Chemotherapy of Chagas Disease: Relevance, Current Limitations and New Approaches. Acta Trop. 2010;115:55–68. doi: 10.1016/j.actatropica.2009.10.023. - DOI - PubMed
    1. Losada Galván I., Alonso-Padilla J., Cortés-Serra N., Alonso-Vega C., Gascón J., Pinazo M.J. Benznidazole for the Treatment of Chagas Disease. Expert Rev. Anti Infect. Ther. 2021;19:547–556. doi: 10.1080/14787210.2021.1834849. - DOI - PubMed
    1. Magalhães L.M.D., Gollob K.J., Zingales B., Dutra W.O. Pathogen Diversity, Immunity, and the Fate of Infections: Lessons Learned from Trypanosoma cruzi Human–Host Interactions. Lancet Microbe. 2022;3:e711–e722. doi: 10.1016/S2666-5247(21)00265-2. - DOI - PubMed

LinkOut - more resources